Citation Impact
Citing Papers
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2018 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
A High-Resolution STS, EST, and Gene-Based Physical Map of the Hereditary Paraganglioma Region on Chromosome 11q23
1997
Identification of factors associated with high breast cancer risk in the mothers of children with soft tissue sarcoma.
1990
WAF1, a potential mediator of p53 tumor suppression
1993 Standout
At least four different chromosomal regions are involved in loss of heterozygosity in human breast carcinoma
1989
Role for the p53 homologue p73 in E2F-1-induced apoptosis
2000 StandoutNatureNobel
The p53 protein and its interactions with the oncogene products of the small DNA tumor viruses
1990
Growth factors and oncogenes in breast cancer
1990
Ovarian cancer
2014 Standout
Genetic instabilities in human cancers
1998 StandoutNature
A genetic model for colorectal tumorigenesis
1990 Standout
Proliferation, cell cycle and apoptosis in cancer
2001 StandoutNature
Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties
1992 StandoutNobel
APC mutations occur early during colorectal tumorigenesis
1992 StandoutNature
The Hallmarks of Cancer
2000 Standout
Oncogenic pathway signatures in human cancers as a guide to targeted therapies
2005 StandoutNature
Medulloblastoma Growth Inhibition by Hedgehog Pathway Blockade
2002 StandoutScience
Tumor suppressor genes
1991 Standout
Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6
1991 StandoutNature
Genomic organization and precise physical location of protein phosphatase 2A regulatory subunit A beta isoform gene on chromosome band 11q23
1998
Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li–Fraumeni syndrome
1990 StandoutNature
COMMENTARY: p53 Tumor suppressor gene: from the basic research laboratory to the clinic—an abridged historical perspective
1996
Chromosomes, 11q and cancer: a review
1999
Mutations in the p53 gene occur in diverse human tumour types
1989 StandoutNature
The molecular biology of breast cancer
1991
The p53 tumour suppressor gene
1991 StandoutNature
Amplification of a gene encoding a p53-associated protein in human sarcomas
1992 StandoutNature
Tumor suppressor genes and medulloblastoma
1996
Immunity, Inflammation, and Cancer
2010 Standout
Proto‐oncogene amplification and homogeneously staining regions in human breast carcinomas
1990
Cotranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformation
1991
p73 is a human p53-related protein that can induce apoptosis
1997 StandoutNatureNobel
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
1992 StandoutNature
p53 is required for radiation-induced apoptosis in mouse thymocytes
1993 StandoutNature
Paragangliomas of the head and neck region show complete loss of heterozygosity at 11 q22-q23 in chief cells and the flow-sorted dna aneuploid fraction
1998
Detection of loss of heterozygosity in the p53 gene in renal cell carcinoma and bladder cancer using the polymerase chain reaction
1991
Cyclin A and the retinoblastoma gene product complex with a common transcription factor
1991 StandoutNatureNobel
The tumore suppressor p53
1993
Hypermutability and mismatch repair deficiency in RER+ tumor cells
1993 StandoutNobel
Allelic Loss in Colorectal Carcinoma
1989
Comparative Genomic Hybridization for Molecular Cytogenetic Analysis of Solid Tumors
1992 StandoutScience
p53 Mutations in Human Cancers
1991 StandoutScience
Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic Mutations
1994 StandoutScience
p53: oncogene or anti-oncogene?
1990
Tumor Suppressor Genes: The Puzzle and the Promise
1989 Science
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
2006 StandoutNature
Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form.
1990
Frequent mutations in the p53 tumor suppressor gene in human leukemia T-cell lines.
1990
Frequency and structure of p53 rearrangements in human osteosarcoma.
1990
Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms
1990 StandoutScience
Allelic Loss of Chromosome 17P in Urothelial Cancer: Strong Association with Invasive Phenotype
1992 StandoutNobel
Frequent Mutations in the p53 Tumor Suppressor Gene in Human Leukemia T-Cell Lines
1990
Linkage of Early-Onset Familial Breast Cancer to Chromosome 17q21
1990 StandoutScience
p53: A Frequent Target for Genetic Abnormalities in Lung Cancer
1989 StandoutScience
Genetic Dissection of Complex Traits
1994 StandoutScience
Type 1 Neurofibromatosis Gene: Identification of a Large Transcript Disrupted in Three NF1 Patients
1990 StandoutScience
Tumor Rejection After Direct Costimulation of CD8 + T Cells by B7-Transfected Melanoma Cells
1993 StandoutScienceNobel
Cancer Genome Landscapes
2013 StandoutScience
Growth Factors and Cancer
1991 StandoutScience
G 1 Events and Regulation of Cell Proliferation
1989 StandoutScience
Incidence Trends of Adenocarcinoma of the Cervix in 13 European Countries
2005
Allelotyping of ductal carcinoma in situ of the breast: deletion of loci on 8p, 13q, 16q, 17p and 17q.
1995
The Molecular Biology of Axon Guidance
1996 StandoutScience
Association of Human Papillomavirus Types 16 and 18 E6 Proteins with p53
1990 StandoutScience
Control of Angiogenesis in Fibroblasts by p53 Regulation of Thrombospondin-1
1994 StandoutScience
Activation of the Estrogen Receptor Through Phosphorylation by Mitogen-Activated Protein Kinase
1995 StandoutScience
Mutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
2000 StandoutScience
Chromosome 17 Deletions and p53 Gene Mutations in Colorectal Carcinomas
1989 StandoutScience
Mechanisms of p53 loss in human sarcomas.
1990
Suppression of Human Colorectal Carcinoma Cell Growth by Wild-Type p53
1990 StandoutScience
CDO: An Oncogene-, Serum-, and Anchorage-regulated Member of the Ig/Fibronectin Type III Repeat Family
1997
Works of James Mackay being referenced
Partial deletion of chromosome 11p in breast cancer correlates with size of primary tumour and oestrogen receptor level
1988
ALLELE LOSS ON SHORT ARM OF CHROMOSOME 17 IN BREAST CANCERS
1988
Psychosocial impact of breast/ovarian (BRCA 1/2) cancer-predictive genetic testing in a UK multi-centre clinical cohort
2004
Evidence implicating at least two genes on chromosome 17p in breast carcinogenesis
1990
Definition and refinement of a region of loss of heterozygosity at 11q23.3-q24.3 in epithelial ovarian cancer associated with poor prognosis.
1996
Results of Annual Screening in Phase I of the United Kingdom Familial Ovarian Cancer Screening Study Highlight the Need for Strict Adherence to Screening Schedule
2012